Treatment of Schizophrenia
Schizophrenia is a severe psychiatric disorder characterized by positive symptoms (hallucinations, delusions, disorganized thinking) and negative symptoms (flat affect, social withdrawal, anhedonia). Antipsychotic medications combined with psychosocial support are the cornerstone of treatment.
Managing Schizophrenia effectively requires a combination of medical treatment, lifestyle modification, and regular monitoring. With a structured management plan, most people with Schizophrenia can maintain a good quality of life and prevent serious complications.
First-Line Treatment Principles
- ✓Establish accurate diagnosis with standardised rating scales (PHQ-9, GAD-7, YMRS, PANSS)
- ✓SSRIs or SNRIs as first-line for depression, anxiety disorders, OCD, and PTSD
- ✓Lithium or valproate as mood stabilisers in bipolar disorder
- ✓Antipsychotics for schizophrenia; clozapine for treatment-resistant cases
- ✓Psychotherapy (CBT, IPT, DBT) as first-line or adjunct in most psychiatric conditions
What to Do Now
- Learn your personal risk factors for Schizophrenia (family history, age, lifestyle)
- Attend regular health check-ups and screening tests appropriate for your age and risk
- Track new or changing symptoms, especially those associated with Schizophrenia
- Use our AI symptom checker to assess whether your symptoms fit an early Schizophrenia pattern
- Discuss preventive strategies and early monitoring with your GP
- Build a personalised management plan with your GP or specialist
- Adhere consistently to prescribed medications — do not stop without medical advice
- Adopt a Schizophrenia-appropriate diet (anti-inflammatory, low-glycaemic, or disease-specific)
Medications Used in Schizophrenia
Haloperidol is an antipsychotic used to manage schizophrenia, bipolar disorder, and acute psychosis by modulating dopamine and serotonin neurotransmission.
Chlorpromazine is an antipsychotic used to manage schizophrenia, bipolar disorder, and acute psychosis by modulating dopamine and serotonin neurotransmission.
Risperidone is an antipsychotic used to manage schizophrenia, bipolar disorder, and acute psychosis by modulating dopamine and serotonin neurotransmission.
Olanzapine is an antipsychotic used to manage schizophrenia, bipolar disorder, and acute psychosis by modulating dopamine and serotonin neurotransmission.
Quetiapine is an antipsychotic used to manage schizophrenia, bipolar disorder, and acute psychosis by modulating dopamine and serotonin neurotransmission.
Aripiprazole is an antipsychotic used to manage schizophrenia, bipolar disorder, and acute psychosis by modulating dopamine and serotonin neurotransmission.
Clozapine is an antipsychotic used to manage schizophrenia, bipolar disorder, and acute psychosis by modulating dopamine and serotonin neurotransmission.
Paliperidone is an antipsychotic used to manage schizophrenia, bipolar disorder, and acute psychosis by modulating dopamine and serotonin neurotransmission.
Non-Pharmacological Management
- •Psychotherapy: CBT for depression, anxiety, OCD, PTSD; DBT for borderline PD; ACT for chronic conditions
- •Regular aerobic exercise: 150 min/week — reduces depression scores comparably to antidepressants in mild-moderate MDD
- •Sleep hygiene: critical in depression, bipolar, and anxiety — circadian rhythm stabilisation
- •Alcohol and substance avoidance: major driver of psychiatric deterioration
- •Social support and peer support groups
- •Mindfulness-based cognitive therapy (MBCT) to prevent MDD relapse
- •Crisis planning: safety plan, emergency contacts, medication access
Treatment Goals
Monitoring Parameters
- ◆Validated symptom scales: PHQ-9 (depression), GAD-7 (anxiety), MADRS, YMRS — at each visit
- ◆Side effect monitoring: weight, metabolic parameters (antipsychotics), thyroid (lithium), LFTs (valproate)
- ◆Lithium levels: 5–7 days after initiation/dose change; then every 3–6 months when stable (target 0.6–1.0 mmol/L)
- ◆ECG: QTc monitoring with antipsychotics (ziprasidone, amisulpride, haloperidol)
- ◆Metabolic syndrome screening: waist circumference, BP, fasting glucose, lipids — annually on antipsychotics
- ◆AIMS for tardive dyskinesia (antipsychotics) — 6-monthly
Red Flags — When to Escalate
- ⚠Any of the characteristic symptoms of Schizophrenia — even mild — in a high-risk individual
- ⚠Progressive worsening of early warning signs over weeks
- ⚠Laboratory abnormalities (e.g., blood sugar, inflammatory markers) without full symptoms
- ⚠Unexplained weight loss, night sweats, or fatigue persisting >2 weeks
- ⚠Strong family history of Schizophrenia combined with new relevant symptoms
- ⚠Sudden worsening of Schizophrenia symptoms despite established treatment
Escalation Criteria
- →Active suicidal ideation with intent/plan → emergency psychiatric assessment; hospitalisation if risk confirmed
- →Psychotic relapse in schizophrenia → urgent psychiatric review; consider clozapine if ≥2 antipsychotic failures
- →Bipolar manic episode → inpatient; optimise mood stabiliser; antipsychotic augmentation
- →Treatment-resistant depression (≥2 failed SSRI trials) → augmentation (lithium, aripiprazole), referral, TMS/ECT consideration
Special Populations
Clinical Insights
Compare With Similar Conditions
Not sure about your symptoms?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.
Use AI Symptom Checker →